Drug Shortage Report for DEPO-MEDROL

Last updated on 2025-11-20 History
Report ID 267801
Drug Identification Number 00030759
Brand name DEPO-MEDROL
Common or Proper name DEPO-MEDROL
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) METHYLPREDNISOLONE ACETATE
Strength(s) 40MG
Dosage form(s) SUSPENSION
Route of administration INTRASYNOVIAL INTRAMUSCULAR INTRALESIONAL INTRA-ARTICULAR INTRASYNOVIAL INTRAMUSCULAR INTRALESIONAL INTRA-ARTICULAR
Packaging size 10 X 1ML
ATC code H02AB
ATC description CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2025-11-19
Estimated end date 2025-12-15
Actual end date
Shortage status Actual shortage
Updated date 2025-11-20
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2025-11-20 English Compare
v9 2025-11-19 French Compare
v8 2025-11-19 English Compare
v7 2025-10-29 French Compare
v6 2025-10-29 English Compare
v5 2025-10-22 French Compare
v4 2025-10-22 English Compare
v3 2025-10-11 English Compare
v2 2025-09-25 French Compare
v1 2025-09-25 English Compare

Showing 1 to 10 of 10